GeneDx Holdings (WGS) Short term Debt (2020 - 2023)

GeneDx Holdings (WGS) has reported Short term Debt for 4 consecutive years, with $4.3 million the latest figure, recorded in Q1 2023.

• In Q1 2023, Short term Debt rose 33.3% year-over-year to $4.3 million; the TTM figure through Mar 2023 stood at $4.3 million (up 33.3% YoY), while the FY2022 annual figure was $3.6 million, up 36.98% from the prior year.
• Short term Debt grew to $4.3 million in Q1 2023 per WGS's latest filing, from $3.6 million in the prior quarter.
• Across five years, Short term Debt topped out at $4.3 million in Q1 2023 and bottomed at $797000.0 in Q1 2021.
• Historically, Short term Debt has averaged $2.3 million across 4 years, with a median of $2.1 million in 2022.
• On a YoY basis, Short term Debt climbed as much as 306.15% in 2022 and fell as far as 28.28% in 2022.
• GeneDx Holdings' Short term Debt stood at $1.4 million in 2020, then soared by 84.07% to $2.6 million in 2021, then soared by 36.98% to $3.6 million in 2022, then climbed by 20.09% to $4.3 million in 2023.
• Business Quant data shows WGS's Short term Debt at $4.3 million in Q1 2023, $3.6 million in Q4 2022, and $1.8 million in Q3 2022.